Gilead Sciences, Inc (NASDAQ:GILD) is a biopharmaceutical company. The Company focuses on the development and commercialization of human therapeutics for life threatening diseases. Gilead Sciences, Inc witnessed volume of 37.67 million shares during last trade however it holds an average trading capacity of 8.15 million shares.